Lomitapide

Details

Files

Generic Name:

Lomitapide

Project Status:

Complete

Therapeutic Area:

Hypercholesterolemia, homozygous familial

Manufacturer:

Aegerion Pharmaceuticals (Canada) Ltd.

Call for patient/clinician input open:

July 9, 2014

Brand Name:

Juxtapid

Project Line:

Reimbursement Review

Project Number:

SR0386-000

Call for patient/clinician input closed:

August 28, 2014

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hypercholesterolemia, Homozygous Familial

Recommendation Type:

Do not list

Final Recommendation:

April 17, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : July 8, 2014